India faces a $11.4 trillion diabetes burden, second only to the US. Global study highlights costs, prevention, and global ...
Company expects preliminary unaudited AUCATZYL® net product revenue of approximately $24 million for the fourth quarter of 2025 and approximately $75 million for the full year of 2025Autolus ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback